Featured Image

Why is it important?

Important for decision making in initiating Lenvatinib for RR-DTC

Read the Original

This page is a summary of: Exploratory analysis of prognostic factors for lenvatinib in radioiodine‐refractory differentiated thyroid cancer, Head & Neck, April 2019, Wiley,
DOI: 10.1002/hed.25784.
You can read the full text:

Read

Contributors

The following have contributed to this page